NO783143L - Fremgangsmaate ved fremstilling av herpesvaksine - Google Patents

Fremgangsmaate ved fremstilling av herpesvaksine

Info

Publication number
NO783143L
NO783143L NO783143A NO783143A NO783143L NO 783143 L NO783143 L NO 783143L NO 783143 A NO783143 A NO 783143A NO 783143 A NO783143 A NO 783143A NO 783143 L NO783143 L NO 783143L
Authority
NO
Norway
Prior art keywords
herping
vaccine
procedures
manufacture
herping vaccine
Prior art date
Application number
NO783143A
Other languages
English (en)
Other versions
NO153692C (no
NO153692B (no
Inventor
Vivian Larson
Ernest Dale Lehman
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO783143L publication Critical patent/NO783143L/no
Publication of NO153692B publication Critical patent/NO153692B/no
Publication of NO153692C publication Critical patent/NO153692C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO783143A 1977-09-19 1978-09-18 Fremgangsmaate ved fremstilling av en antigen, immunogen subenhet av herpes simplex type 1 (hsv1) eller type 2 subenhet (hsv2). NO153692C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83459877A 1977-09-19 1977-09-19

Publications (3)

Publication Number Publication Date
NO783143L true NO783143L (no) 1979-03-20
NO153692B NO153692B (no) 1986-01-27
NO153692C NO153692C (no) 1986-05-07

Family

ID=25267310

Family Applications (1)

Application Number Title Priority Date Filing Date
NO783143A NO153692C (no) 1977-09-19 1978-09-18 Fremgangsmaate ved fremstilling av en antigen, immunogen subenhet av herpes simplex type 1 (hsv1) eller type 2 subenhet (hsv2).

Country Status (9)

Country Link
EP (1) EP0001365B2 (no)
JP (1) JPS5484024A (no)
CA (1) CA1114294A (no)
DE (1) DE2862086D1 (no)
DK (1) DK411878A (no)
FI (1) FI66020C (no)
IE (1) IE47364B1 (no)
IT (1) IT1110864B (no)
NO (1) NO153692C (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374127A (en) * 1977-09-19 1983-02-15 Merck & Co., Inc. Herpes sub unit vaccine
US4452734A (en) * 1980-02-11 1984-06-05 Merck & Co., Inc. Herpes subunit vaccine
FR2483779A1 (fr) * 1980-06-05 1981-12-11 Synthelabo Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins
US4317811A (en) * 1980-09-11 1982-03-02 Merck & Co., Inc. Herpes simplex type 1 subunit vaccine
ATE39054T1 (de) * 1982-03-24 1988-12-15 Univ Birmingham Dns viren-vakzin.
US5219567A (en) * 1982-03-24 1993-06-15 The University Of Birmingham Vaccine against herpes viruses
CA1201987A (en) * 1982-03-24 1986-03-18 Gordon R.B. Skinner Vaccine against dna viruses
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
NZ209307A (en) * 1983-08-30 1990-07-26 Genentech Inc Diagnostic product: antigenic peptide produced by recombinant dna techniques
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
JPS6051120A (ja) * 1983-08-31 1985-03-22 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニットワクチン
JPS6153226A (ja) * 1984-08-24 1986-03-17 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニツトワクチンの精製方法
EP0312164A1 (en) * 1987-10-16 1989-04-19 Merck & Co. Inc. Purification of recombinant epstein-barr virus antigens from vero cells, yeast cells or L cells
US5081010A (en) * 1989-02-09 1992-01-14 Eastman Kodak Company Extraction composition, test kit and their use to extract or determine herpes simplex viral antigen
DE4033446A1 (de) * 1990-10-20 1992-04-23 Bayer Ag Impfstoffe gegen equine herpesviren und ihre herstellung
US5334503A (en) * 1991-10-08 1994-08-02 Eastman Kodak Company Test kit and method for the detection of microorganisms associated with periodontal diseases using surfactant mixture as extraction composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962421A (en) * 1973-06-18 1976-06-08 American Home Products Corporation Method for the disruption of lipid-containing viruses

Also Published As

Publication number Publication date
FI66020B (fi) 1984-04-30
NO153692C (no) 1986-05-07
FI782769A (fi) 1979-03-20
EP0001365A1 (en) 1979-04-04
NO153692B (no) 1986-01-27
IT1110864B (it) 1986-01-06
FI66020C (fi) 1984-08-10
IE47364B1 (en) 1984-03-07
JPS5484024A (en) 1979-07-04
DE2862086D1 (en) 1982-12-16
IE781880L (en) 1979-03-19
IT7851116A0 (it) 1978-09-15
EP0001365B1 (en) 1982-11-10
DK411878A (da) 1979-03-20
CA1114294A (en) 1981-12-15
EP0001365B2 (en) 1987-09-23

Similar Documents

Publication Publication Date Title
NO781082L (no) Fremgangsmaate ved fremstilling av jodofore forbindelser
SE7808356L (sv) Forfarande for framstellning av liposomer
NO148712C (no) Fremgangsmaate ved fremstilling av etylidendiacetat
NO151225C (no) Fremgangsmaate ved fremstilling av pasteurellosis-vaksiner
NO782484L (no) Fremgangsmaate for fremstilling av sulfobetainer
SE7812575L (sv) Forfarande for framstellning av hydrofob kiseldioxid
NO773682L (no) Fremgangsmaate ved fremstilling av furocumariner
NO783143L (no) Fremgangsmaate ved fremstilling av herpesvaksine
NO781168L (no) Fremgangsmaate ved fremstilling av diasepinderivater
NO781678L (no) Fremgangsmaate ved fremstilling av olefiner
NO780777L (no) Fremgangsmaate ved fremstilling av 1-azaxanthon-3-carboxylsyrer
NO783185L (no) Fremgangsmaate ved fremstilling av serinol
BR7800822A (pt) Process for the preparation of new esters
NO783705L (no) Fremgangsmaate ved fremstilling av quinazolinderivater
NO782411L (no) Fremgangsmaate ved fremstilling av thienopyridinderivater
NO781391L (no) Fremgangsmaate ved fremstilling av auranofin
NO780190L (no) Fremgangsmaate ved fremstilling av urea
NO783233L (no) Fremgangsmaate ved fremstilling av 3-(tetrazol-5-yl)-1-azaxanthoner
NO782242L (no) Fremgangsmaate ved fremstilling av auranofin
NO791220L (no) Fremgangsmaate ved fremstilling av 4-aza-17-substituert-5alfa-androstan-3-oner
NO781111L (no) Fremgangsmaate ved fremstilling av avkoffeinert kaffe
SE7809549L (sv) Forfarande for framstellning av antiperspirantmedel
SE7809202L (sv) Forfarande for framstellning av 2-klorsulfinylazetidin-4-oner
NO150606C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme substituerte kromoner
NO771576L (no) Fremgangsmaate for fremstilling av di-n-propylacetonitril